Dr. Stuart Himmelstein, DC, a Philadelphia-based chiropractor, examines how peripheral neuropathy is evaluated in ...

One cause of foot pain is diabetic neuropathy, the development of pain, discomfort and other related health issues because of ...

Patients receiving chemotherapy-induced peripheral neuropathy experience persistent, clinically significant symptoms months after treatment.

Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those taking GLP-1 receptor agonists.

Dr. Evan Norum, DC, BCN, from Advantage Neuropathy, joins us on The Morning Blend to discuss the types of neuropathies, ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Chronic pain affects more than 50 million Americans, yet for decades, treatment options for pain that persists in the absence ...

Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural, which carry sensory signals, and the tibial, which carry both sensory and ...

Dr. Evan Norum, DC, BCN, founder of Advantage Neuropathy, joins us on The Morning Blend to discuss how Neuropathy may affect ...

Explore comprehensive treatments for CIDP, including corticosteroids, plasma exchange, immunoglobulin therapy, and others.

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...